COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 07:00, il y a 6 mois 1 jour Newron announces nominations to its Board of Directors at upcoming Annual General Meeting Newron Pharmaceuticals S.p.A. announces nominations for new Board members and resignations of current members ahead of its Annual General Meeting. Full agenda to be released on March 24, 2026 Board Of Directors Annual General Meeting Nominations Newron Pharmaceuticals Resignations
COMMUNIQUÉ RÉGLEMENTÉ publié le 18/03/2026 à 07:00, il y a 6 mois 1 jour Mersen: A resilient performance in 2025, return to growth expected in 2026 Mersen demonstrates resilient performance in 2025 with sales of €1,186 million and 2026 guidance for organic sales growth between 2% and 6%. Return to positive free cash flow ahead of schedule Mersen Sales Growth Free Cash Flow Resilient Performance 2026 Guidance
COMMUNIQUÉ RÉGLEMENTÉ publié le 18/03/2026 à 07:00, il y a 6 mois 1 jour Mersen : Performance résiliente en 2025, retour attendu de la croissance en 2026 Mersen affiche une performance résiliente en 2025 avec un chiffre d'affaires de 1 186 M€, une marge d'EBITDA maintenue à 16% et un retour anticipé au free cash-flow positif. Objectifs 2026 : croissance organique et marge EBITDA autour de 16% Chiffre D'affaires Croissance EBITDA Mersen Performance
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 07:00, il y a 6 mois 1 jour 2025 annual results: strong improvement in financial earnings and cash-flows Exail Technologies achieved significant financial growth in 2025 with record order intake of €844 million (+87%), revenue growth of +28%, and strengthened balance sheet post fundraising of €300 million. Operational milestones include delivering mine countermeasures to navies and increasing production capacity for navigation systems Financial Growth Record Order Intake Exail Technologies Operational Milestones Strengthened Balance Sheet
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 07:00, il y a 6 mois 1 jour Résultats annuels 2025 : forte amélioration des résultats et des flux de trésorerie
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 07:00, il y a 6 mois 1 jour Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Sanofi's venglustat receives Breakthrough Therapy designation in the US for type 3 Gaucher disease, a rare lysosomal storage disorder. Positive results from the LEAP2MONO study show significant improvements in neurological symptoms Sanofi Breakthrough Therapy Venglustat Gaucher Disease Neurological Symptoms
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 07:00, il y a 6 mois 1 jour Communiqué de presse : Le venglustat de Sanofi a reçu la désignation de thérapie innovante aux États-Unis pour la maladie de Gaucher de type 3 Sanofi's venglustat receives innovative therapy designation in the US for Gaucher disease type 3. Positive results from the LEAP2MONO study reinforce its potential as a treatment option FDA Sanofi Innovative Therapy Venglustat Gaucher Disease
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 06:55, il y a 6 mois 1 jour Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China Heidelberg Pharma to receive milestone payment from partner Huadong for clinical study with HDP-101 in China. First patient dosed in Phase I study evaluating safety, tolerability, and efficacy China Clinical Study Heidelberg Pharma HDP-101 Milestone Payment
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 06:55, il y a 6 mois 1 jour SMG reports strong 2025 results with significant margin uplift SMG Swiss Marketplace Group reports strong 2025 financial results with revenue of CHF 332.0 million and Adjusted EBITDA up to CHF 180.2 million, lifting margin to 54.3%. Continues innovating with AI for user experience and efficiency Adjusted EBITDA AI Innovation Revenue Growth 2025 Financial Results SMG Swiss Marketplace Group
COMMUNIQUÉ DE PRESSE publié le 18/03/2026 à 06:55, il y a 6 mois 1 jour TAG Immobilien AG exceeds guidance for the 2025 financial year TAG Immobilien AG exceeds guidance for the 2025 financial year, reporting strong financial performance and growth in Germany and Poland. Acquisitions and decarbonisation strategy milestones achieved Acquisitions Germany TAG Immobilien AG Poland 2025 Financial Year
Publié le 18/09/2026 à 18:34, il y a 1 jour 6 heures Disclosure of transactions in own shares from September 14 to September 18, 2026
Publié le 18/09/2026 à 18:34, il y a 1 jour 6 heures Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
Publié le 18/09/2026 à 17:45, il y a 1 jour 7 heures Communiqué de presse_Carrefour Bond_Septembre 2026
Publié le 19/09/2026 à 00:55, il y a 1 jour Gossan Resources Announces Changes to Board and Management
Publié le 18/09/2026 à 22:00, il y a 1 jour 2 heures Silver Tiger Announces Results of Annual and Special Meeting
Publié le 18/09/2026 à 20:35, il y a 1 jour 4 heures Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Publié le 18/09/2026 à 14:30, il y a 1 jour 10 heures AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Publié le 19/09/2026 à 16:40, il y a 8 heures 17 minutes 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens
Publié le 19/09/2026 à 13:15, il y a 11 heures 42 minutes Eurobattery Minerals AB has received information regarding court judgment and criminal suspicion concerning the CEO
Publié le 19/09/2026 à 07:30, il y a 17 heures 27 minutes Hong Kong sets out initiatives to secure long-term development of pillar industries
Publié le 18/09/2026 à 18:44, il y a 1 jour 6 heures EQS-Adhoc: Enapter AG announces preliminary, unaudited figures for the first half of 2026 and restructures its US sales operations – one-off expense of EUR 17 million